Clinical Research as a Care Option for Patients

Patient types for expanded care options

Research as a care option is poised to change the health care landscape. But before diving into the various benefits of research as a care option, it’s a good idea to consider the types of patient populations in need of expanded care options.

For example, elderly individuals will demand treatment options beyond the customary, such as the ability to participate in clinical trials as a care option. The goal here is not only to extend life, but improve quality of life and functional health as long as possible.

Presenters:

Jeff James
Chief Executive Officer, Wilmington Health

Jeff James has more than 20 years of experience as a medical practice executive. As the current CEO of Wilmington Health and a founder of Innovo Research, James sees the convergence of pharma and the traditional health care system from both perspectives. He is one of the pioneers associated with developing clinical research as a care option and demonstrating its connection to an ACO’s population health initiatives.  

Wilmington Health is a multispecialty physician practice with nearly 200 providers and a reputation of high performance as an accountable care organization (ACO). As a site management company comprised of other ACOs, Innovo Research leverages Wilmington Health’s knowledge of population health and clinical research to assist ACOs in developing effective research programs that are in line with their Triple Aim aspirations.  

Prior to joining Wilmington Health, James served as the chief financial and operating officer of Christie Clinic. He has served on the Board of the AMGA and is a frequent national speaker. A certified public accountant, James holds a Bachelor of Arts in finance and a Master of Business Administration.

Cynthia Senerchia
Vice President, Quality and Regulatory Compliance, Optum Analytics

Cynthia Senerchia is responsible for bringing together Optum^® Analytics processes and assets into a coherent, auditable system that improves the efficiency of our processes, and assures demonstrable compliance with relevant regulations.

Her career began in 1984 at the Beth Israel Hospital in Boston, Massacusetts, coordinating multiple cardiovascular research trials.

This led to a career in an academic research organization in 1994 as a founder and director of Clinical Affairs at the Cardiovascular Data Analysis Center. This center was later named Harvard Clinical Research Institute. It is now known as Baim Research Institute. 

In 1999, Senerchia joined PhaseForward, now Oracle Health Sciences. She first served in clinical services leading trial system quality control, and later as director of Quality and Regulatory Compliance.

She joined Optum Analytics in 2012 and currently focuses on FDA compliance, as well as HIPAA and HITECH certification.

Senerchia is an advanced practice Nurse Practitioner from the University of South Florida. She maintains a Regulatory Affairs Certification (RAC) for U.S. regulations, is a certified HIPAA Privacy and Security Expert, and a certified de-identification associate in HITRUST.